Blood test may speed up deadly fungal infection diagnosis
NCT ID NCT07272915
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at a blood test called Beta-D-glucan (BDG) to see how well it detects invasive fungal infections in people with weak immune systems. Researchers tested 280 patients and checked if two positive results within 15 days confirmed an infection. The goal is to help doctors diagnose faster and start treatment sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Beta-D-glucan (BDG) blood test
What this could lead to
If successful, this could improve how quickly and accurately doctors diagnose serious fungal infections, potentially saving lives.
What could go wrong
This is a completed study analyzing past data, not a new treatment. The test may still produce false positives or negatives, and results may not apply to all hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Nancy
Vandœuvre-lès-Nancy, 54500, France